Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Inducing survivin in normal tissues can protect against radiation damage.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Finasteride may improve prostate cancer treatment outcomes.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Adalimumab helped control a child's severe eye disease when other treatments failed.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Minoxidil improves hair loss in breast cancer patients on CDK4/6-inhibitor therapy.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Biological therapy boosts the immune system to effectively fight melanoma.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.